Trial · NCT07907848
Psychotherapy in Patients With Endometriosis: Cognitive Behavioral Therapy Versus Acceptance and Commitment Therapy
NCT07907848, Not applicable, Not yet recruiting, Fiammetta Cosci
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Psychotherapy in Patients With Endometriosis: Cognitive Behavioral Therapy Versus Acceptance and Commitment Therapy. Trials, record NCT07907848. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907848
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Psychotherapy in Patients With Endometriosis: Cognitive Behavioral Therapy Versus Acceptance and Commitment Therapy
- NCT number
- NCT07907848
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 128 participants, estimated
- Lead sponsor
- Fiammetta Cosci
- Conditions
- Endometriosis, Adenomyosis
- Interventions
- Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT)
- First posted
- 2026-10-30
- Last updated
- 2026-11-04
Source ClinicalTrials.gov
Registered outcomes26
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | EQ-5D-5L | change from baseline to 6-month follow up | The primary outcome will be health-related quality of life, assessed using the EQ-5D-5L (health states range from 11111, representing the best health state, to 55555, representing the worst health state). |
| Secondary | Endometriosis Health Profile Questionnaire (EHP-5) | change from baseline to 6-month follow up | Endometriosis Health Profile Questionnaire (EHP-5), with higher scores indicating worse endometriosis-related quality of life. |
| Secondary | Brief Pain Inventory - Short Form (BPI-SF) | change from baseline to 6-month follow up | Brief Pain Inventory - Short Form (BPI-SF), with higher scores indicating greater pain-related disability. |
| Secondary | Psychological Pain Index (PPI) | change from baseline to 6-month follow up | Psychological Pain Index (PPI), with higher scores indicating greater psychological pain. |
| Secondary | Symptom Questionnaire (SQ) | change from baseline to 6-month follow up | Symptom Questionnaire (SQ), with higher scores indicating greater psychological distress. |
| Secondary | Somatic Symptom Disorder - B Criteria Scale (SSD-12) | change from baseline to 6-month follow up | Somatic Symptom Disorder - B Criteria Scale (SSD-12), with higher scores indicating greater somatic symptom burden. |
| Secondary | Pain Catastrophizing Scale (PCS) | change from baseline to 6-month follow up | Pain Catastrophizing Scale (PCS), with higher scores indicating greater pain catastrophizing. |
| Secondary | Chronic Pain Acceptance Questionnaire (CPAQ) | change from baseline to 6-month follow up | Chronic Pain Acceptance Questionnaire (CPAQ), with higher scores indicating greater pain acceptance. |
| Secondary | Multidimensional Psychological Flexibility Inventory (MPFI) | change from baseline to 6-month follow up | Multidimensional Psychological Flexibility Inventory (MPFI), with higher scores indicating greater psychological flexibility/inflexibility. |
| Secondary | Acceptance and Action Questionnaire - II (AAQ-II) | change from baseline to 6-month follow up | Acceptance and Action Questionnaire - II (AAQ-II), with higher scores indicating greater psychological inflexibility. |
1 to 10 of 26Source ClinicalTrials.gov
See all 26 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers28
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07907848
GET https://conductscience.org/api/trials/v1/NCT07907848/registered?page=2